PATRICIA CARMEN
MUÑOZ GARCÍA
Catedrática de universidad
National and Kapodistrian University of Athens
Atenas, GreciaPublicaciones en colaboración con investigadores/as de National and Kapodistrian University of Athens (13)
2024
2023
2021
-
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM
The Lancet Infectious Diseases, Vol. 21, Núm. 12, pp. e375-e386
2020
-
Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey
Mycoses, Vol. 63, Núm. 5, pp. 420-429
2019
2018
-
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals
Clinical Microbiology and Infection, Vol. 24, Núm. 10, pp. 1070-1076
-
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Clinical Microbiology and Infection, Vol. 24, pp. e1-e38
2017
-
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study
Intensive Care Medicine, Vol. 43, Núm. 4, pp. 509-518
2014
-
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013
Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 5-26
-
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: Diseases caused by black fungi
Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 47-75
-
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
Clinical Microbiology and Infection, Vol. 20, Núm. S3, pp. 27-46
2013
-
A research agenda on the management of intra-abdominal candidiasis: Results from a consensus of multinational experts
Intensive Care Medicine, Vol. 39, Núm. 12, pp. 2092-2106
-
The incidence of AIDS-defining illnesses at a current CD4 count ≥200 cells/μL in the post-combination antiretroviral therapy era
Clinical Infectious Diseases, Vol. 57, Núm. 7, pp. 1038-1047